S&P 500   4,568.73 (+0.52%)
DOW   35,757.08 (+0.22%)
QQQ   377.89 (+1.01%)
AAPL   148.93 (+0.16%)
MSFT   308.86 (-0.10%)
FB   325.15 (+0.17%)
GOOGL   2,749.40 (-0.07%)
TSLA   994.44 (+9.32%)
AMZN   3,325.95 (-0.29%)
NVDA   232.47 (+2.29%)
BABA   176.18 (-0.86%)
NIO   41.28 (+6.17%)
CGC   13.30 (-0.60%)
GE   105.92 (+1.80%)
AMD   122.83 (+2.51%)
MU   69.10 (+2.36%)
T   25.45 (-0.16%)
F   15.84 (-2.70%)
ACB   7.12 (+0.71%)
DIS   172.39 (+1.75%)
PFE   42.94 (-0.51%)
BA   212.19 (-0.37%)
AMC   36.93 (+0.90%)
S&P 500   4,568.73 (+0.52%)
DOW   35,757.08 (+0.22%)
QQQ   377.89 (+1.01%)
AAPL   148.93 (+0.16%)
MSFT   308.86 (-0.10%)
FB   325.15 (+0.17%)
GOOGL   2,749.40 (-0.07%)
TSLA   994.44 (+9.32%)
AMZN   3,325.95 (-0.29%)
NVDA   232.47 (+2.29%)
BABA   176.18 (-0.86%)
NIO   41.28 (+6.17%)
CGC   13.30 (-0.60%)
GE   105.92 (+1.80%)
AMD   122.83 (+2.51%)
MU   69.10 (+2.36%)
T   25.45 (-0.16%)
F   15.84 (-2.70%)
ACB   7.12 (+0.71%)
DIS   172.39 (+1.75%)
PFE   42.94 (-0.51%)
BA   212.19 (-0.37%)
AMC   36.93 (+0.90%)
S&P 500   4,568.73 (+0.52%)
DOW   35,757.08 (+0.22%)
QQQ   377.89 (+1.01%)
AAPL   148.93 (+0.16%)
MSFT   308.86 (-0.10%)
FB   325.15 (+0.17%)
GOOGL   2,749.40 (-0.07%)
TSLA   994.44 (+9.32%)
AMZN   3,325.95 (-0.29%)
NVDA   232.47 (+2.29%)
BABA   176.18 (-0.86%)
NIO   41.28 (+6.17%)
CGC   13.30 (-0.60%)
GE   105.92 (+1.80%)
AMD   122.83 (+2.51%)
MU   69.10 (+2.36%)
T   25.45 (-0.16%)
F   15.84 (-2.70%)
ACB   7.12 (+0.71%)
DIS   172.39 (+1.75%)
PFE   42.94 (-0.51%)
BA   212.19 (-0.37%)
AMC   36.93 (+0.90%)
S&P 500   4,568.73 (+0.52%)
DOW   35,757.08 (+0.22%)
QQQ   377.89 (+1.01%)
AAPL   148.93 (+0.16%)
MSFT   308.86 (-0.10%)
FB   325.15 (+0.17%)
GOOGL   2,749.40 (-0.07%)
TSLA   994.44 (+9.32%)
AMZN   3,325.95 (-0.29%)
NVDA   232.47 (+2.29%)
BABA   176.18 (-0.86%)
NIO   41.28 (+6.17%)
CGC   13.30 (-0.60%)
GE   105.92 (+1.80%)
AMD   122.83 (+2.51%)
MU   69.10 (+2.36%)
T   25.45 (-0.16%)
F   15.84 (-2.70%)
ACB   7.12 (+0.71%)
DIS   172.39 (+1.75%)
PFE   42.94 (-0.51%)
BA   212.19 (-0.37%)
AMC   36.93 (+0.90%)
NASDAQ:RZLT

Rezolute News Headlines

$6.41
-0.09 (-1.38 %)
(As of 10/25/2021 11:20 AM ET)
Add
Compare
Today's Range
$6.41
$6.46
50-Day Range
$6.53
$11.35
52-Week Range
$5.86
$21.11
Volume208 shs
Average Volume43,675 shs
Market Capitalization$55.25 million
P/E RatioN/A
Dividend YieldN/A
Beta3.69

Media Mentions By Week



Rezolute Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RZLT
News Sentiment

0.50

0.37

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RZLT Articles
This Week

4

2

RZLT Articles
Average Week

Get Rezolute News Delivered to You Automatically

Sign up to receive the latest news and ratings for RZLT and its competitors with MarketBeat's FREE daily newsletter.

Rezolute (NASDAQ RZLT) News Headlines Today

SourceHeadline
finance.yahoo.com logoApple’s $19 Screen-Cleaning Cloth Sets High Bar for Brand Extras - Yahoo Finance
finance.yahoo.com - October 21 at 6:51 PM
finance.yahoo.com logoPaintmakers Are Running Out of the Color Blue - Yahoo Finance
finance.yahoo.com - October 20 at 8:12 PM
finance.yahoo.com logoDo Institutions Own Rezolute, Inc. (NASDAQ:RZLT) Shares?
finance.yahoo.com - October 19 at 2:20 PM
nasdaq.com logoCould The Rezolute, Inc. (NASDAQ:RZLT) Ownership Structure Tell Us Something Useful? - Nasdaq
nasdaq.com - October 18 at 6:17 PM
seekingalpha.com logoCRISPR Therapeutics, NRx Pharmaceuticals, Neuronetics among major healthcare premarket losers' pack - Seeking Alpha
seekingalpha.com - October 13 at 3:33 PM
nasdaq.com logoBuy This Dividend Stock Today and Relax - Nasdaq
nasdaq.com - October 13 at 3:33 PM
thestreet.com logo5 Top Stock Decliners for Wednesday: Delta Air Lines, JPMorgan - TheStreet
thestreet.com - October 13 at 3:33 PM
globenewswire.com logoRezolute Announces Pricing of Public Offering of $55 million of Common Stock and Pre-Funded Warrants - GlobeNewswire
globenewswire.com - October 13 at 3:33 PM
nasdaq.com logoStock Market News for Oct 13, 2021 - Nasdaq
nasdaq.com - October 13 at 10:32 AM
finance.yahoo.com logoRezolute Announces Pricing of Public Offering of $55 million of Common Stock and Pre-Funded Warrants, and Concurrent Registered Direct Offering - Yahoo Finance
finance.yahoo.com - October 13 at 10:32 AM
finance.yahoo.com logoRezolute Announces Pricing of Public Offering of $55 million of Common Stock and Pre-Funded Warrants, and Concurrent Registered Direct Offering
finance.yahoo.com - October 13 at 10:32 AM
MarketBeat logoRezolute, Inc. (NASDAQ:RZLT) Short Interest Update
americanbankingnews.com - October 13 at 3:50 AM
streetinsider.com logoAfter-Hours Stock Movers 10/12: (JSPR) (VST) (QCOM) Higher; (RGLS) (STIM) (RZLT) Lower (more...) - StreetInsider.com
streetinsider.com - October 12 at 11:24 PM
globenewswire.com logoRezolute Announces Proposed Public Offering of Common Stock - GlobeNewswire
globenewswire.com - October 12 at 6:24 PM
finance.yahoo.com logoRezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants, and a Concurrent Registered Direct Offering
finance.yahoo.com - October 12 at 6:24 PM
MarketBeat logoRezolute, Inc. (NASDAQ:RZLT) Sees Large Decrease in Short Interest
americanbankingnews.com - October 4 at 9:38 AM
seekingalpha.com logoWarning: RZLT has been downgraded to Very Bearish - Seeking Alpha
seekingalpha.com - September 23 at 5:51 AM
globenewswire.com logoRezolute Presents Results from Two-Week Natural History Study in Congenital Hyperinsulinism Patients on Standard of - GlobeNewswire
globenewswire.com - September 23 at 5:51 AM
finance.yahoo.com logoRezolute Presents Results from Two-Week Natural History Study in Congenital Hyperinsulinism Patients on Standard of Care Therapies at ESPE 2021 - Yahoo Finance
finance.yahoo.com - September 22 at 10:40 PM
finance.yahoo.com logoRezolute Presents Results from Two-Week Natural History Study in Congenital Hyperinsulinism Patients on Standard of Care Therapies at ESPE 2021
finance.yahoo.com - September 22 at 5:40 PM
finance.yahoo.com logoRezolute Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results and Highlights Recent Company Progress - Yahoo Finance
finance.yahoo.com - September 15 at 10:29 PM
globenewswire.com logoRezolute Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results and Highlights Recent Company Progress - GlobeNewswire
globenewswire.com - September 15 at 5:28 PM
finance.yahoo.com logoRezolute Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results and Highlights Recent Company Progress
finance.yahoo.com - September 15 at 5:28 PM
streetinsider.com logoForm 8-K Rezolute, Inc. For: Sep 09 - StreetInsider.com
streetinsider.com - September 13 at 3:23 PM
finance.yahoo.com logoRezolute Announces Initiation of Dosing in the Second Cohort of its Phase 2b Trial of RZ358 for Congenital Hyperinsulinism - Yahoo Finance
finance.yahoo.com - September 9 at 7:13 PM
finance.yahoo.com logoRezolute Announces Initiation of Dosing in the Second Cohort of its Phase 2b Trial of RZ358 for Congenital Hyperinsulinism
finance.yahoo.com - September 9 at 7:13 PM
seekingalpha.com logoXoma shares drop 10% as Wedbush downgrades shares on Novartis candidate discontinuation - Seeking Alpha
seekingalpha.com - September 7 at 2:48 PM
finance.yahoo.com logoRezolute Announces Initiation of Multiple-Ascending Dose Study of RZ402, Rezolute’s Oral PKI for Treatment of DME
finance.yahoo.com - August 10 at 8:37 AM
streetinsider.com logoRezolute to Participate in Upcoming Virtual Healthcare Conferences - StreetInsider.com
streetinsider.com - August 3 at 9:11 AM
markets.businessinsider.com logoIO Biotech Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer - Markets Insider
markets.businessinsider.com - July 10 at 6:43 AM
finance.yahoo.com logoIO Biotech Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer - Yahoo Finance
finance.yahoo.com - July 8 at 3:13 PM
seekingalpha.com logoRezolute to join Russell Microcap Index - Seeking Alpha
seekingalpha.com - June 29 at 1:17 AM
globenewswire.com logoRezolute Added to Russell Microcap® Index - GlobeNewswire
globenewswire.com - June 28 at 10:00 AM
finance.yahoo.com logoRezolute Added to Russell Microcap® Index
finance.yahoo.com - June 28 at 10:00 AM
seekingalpha.com logoOsmotica Pharmaceuticals, Star Equity leads healthcare gainers; Theravance Biopharma, Corbus Pharmaceuticals among major losers - Seeking Alpha
seekingalpha.com - June 25 at 1:41 PM
nasdaq.com logoOppenheimer Bets on These 2 Stocks; Sees at Least 80% Upside Ahead - Nasdaq
nasdaq.com - June 25 at 8:41 AM
finance.yahoo.com logoOppenheimer Bets on These 2 Stocks; Sees at Least 80% Upside Ahead
finance.yahoo.com - June 25 at 12:10 AM
finance.yahoo.com logoIs Rezolute, Inc. (RZLT) A Good Stock To Buy? - Yahoo Finance
finance.yahoo.com - June 21 at 7:49 PM
streetinsider.com logoForm POS AM Rezolute, Inc. - StreetInsider.com
streetinsider.com - June 21 at 2:47 PM
finance.yahoo.com logoThe LGL Group, Inc. (LGL): Hedge Fund Sentiment Unchanged - Yahoo Finance
finance.yahoo.com - June 15 at 8:01 PM
finance.yahoo.com logoWill Rezolute (NASDAQ:RZLT) Spend Its Cash Wisely?
finance.yahoo.com - June 3 at 11:19 AM
finance.yahoo.com logo3 ‘Strong Buy’ Stocks with 100% Upside Potential - Yahoo Finance
finance.yahoo.com - June 2 at 7:28 AM
finance.yahoo.com logoOntario Lottery and Gaming Corporation - EVENING LOTTERY WINNING NUMBERS - May 31, 2021 - Yahoo Finance
finance.yahoo.com - June 1 at 10:06 AM
finance.yahoo.com logoChina reports 23 new coronavirus cases on May 31 vs 27 previous day - Yahoo Finance
finance.yahoo.com - May 31 at 10:29 PM
finance.yahoo.com logoBrazil's Raizen signals IPO filing is imminent - Yahoo Finance
finance.yahoo.com - May 31 at 10:29 PM
finance.yahoo.com logoAustralia's Nine Entertainment signs content deal with Facebook, Google - Yahoo Finance
finance.yahoo.com - May 31 at 10:29 PM
finance.yahoo.com logoChilean health regulator approves Pfizer COVID-19 vaccine for teenagers - Yahoo Finance
finance.yahoo.com - May 31 at 10:29 PM
finance.yahoo.com logoMedia Statement: JBS USA Cybersecurity Attack - Yahoo Finance
finance.yahoo.com - May 31 at 5:29 PM
nasdaq.com logo3 ‘Strong Buy’ Stocks with 100% Upside Potential - Nasdaq
nasdaq.com - May 31 at 5:29 PM
finance.yahoo.com logo3 ‘Strong Buy’ Stocks with 100% Upside Potential
finance.yahoo.com - May 31 at 12:28 PM
Get Rezolute News Delivered to You Automatically

Sign up to receive the latest news and ratings for RZLT and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/25/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.